The Sinatra Solution: Metabolic Cardiology
There's new hope for preventing and treating heart disease.
If you suffer from heart disease, Dr. Stephen T. Sinatra has the solution you've been looking for: maximize the amount of oxygen your heart extracts from your bloodstream by accelerating the rate at which your cells convert nutrients to energy.
This can be achieved by following Dr. Sinatra's energy-enhancing nutritional approach. This approach focuses on the supplemental use of three amazing bioenergetic nutrients: Coenzyme Q10, L-carnitine, and D-ribose.
The synergistic combination of these nutrients essentially charges up every body cell to function at optimal capacity. So, not only will you experience renewed heart health with all that energy, you'll also gain a greater sense of overall well-being.
We earn a commission for purchases made through the following links.
Book details
- Author
- Stephen Sinatra
- Imprint
- Basic Health Publications, Inc., an imprint of Turner Publishing Company
- Published
- Formats
- Paperback, Hardcover
- Subjects
- Health & Fitness › Diseases & Conditions › Heart
- Topics
- heart disease · coenzyme Q10 · L-carnitine · D-ribose · heart disease prevention · nutritional supplements · cellular energy
- ISBN-13
- 9781591202912 (Paperback)9781683367710 (Hardcover)
About the author
STEPHEN T. SINATRA was a board-certified cardiologist and certified bioenergetic psychotherapist with more than 40 years of clinical experience and the author of more than 30 books and medical textbooks. His books include Reverse Heart Disease Now, The Sinatra Solution: Metabolic Cardiology and The Great Cholesterol Myth.
Sinatra was a Fellow of the American College of Cardiology and the American College of Nutrition. He earned his M.D. from Albany Medical College and served as Chief of Cardiology and Director of Medical Education at Manchester Memorial Hospital in Connecticut, and as Assistant Clinical Professor of Medicine at the University of Connecticut School of Medicine.
Sinatra passed away on June 19, 2022, following a brief battle with pancreatic cancer.